| |
|
|
Fall 2007 Schedule |
|
| |
|
|
|
|
| Date |
Starts |
Ends |
Presenter / Title |
Location |
Tuesday
September 11, 2007 |
1:00 PM |
1:50 PM |
Stephen Fesik, Abbott Laboratories, Distinguished Lecturer, "Discovery of Bcl-2 Family Inhibitors for the Treatment of Cancer" |
202 Light Hall |
Wednesday
September 12, 2007 |
12:15 PM |
1:15 PM |
Charles Sanders, Department of Biochemistry, Vanderbilt University, "Structural Basis for Potassium Channel Modulation by KCNE1" |
1220 MRBIII |
Wednesday
September 19, 2007
|
12:15 PM |
1:15 PM |
Eva Harth, Vanderbilt University, Department of Chemistry, "Multifunctional Nanostructures: Targeted Delivery and Transport Across Biological Membranes" |
1220 MRBIII |
Wednesday
October 3, 2007
|
12:15 PM |
1:15 PM |
Richard Hargreaves, Vice President for Imaging, Merck, Inc., "Imaging to Improve Probability of Success in Drug Development" |
1220 MRBIII |
Wednesday
October 10, 2007
|
12:15 PM |
1:15 PM |
Charles Hong, Vanderbilt University, Department of Medicine, "Zebrafish: Chemical Tool Box for Stem Cell Manipulation" |
1220 MRBIII |
Thursday
October 11, 2007 |
4:00 PM |
5:00 PM |
Special Lecture: Bengt Samuelsson, Nobel Laureate in Physiology/Medicine, "From Biochemical Mechanisms to Novel Drug Targets: The 5-Lipoxygenase Pathway." Co-Sponsored by the Oates Institute of Experimental Therapeutics and the Vanderbilt Insitute of Chemical Biology. Podcast |
208 Light Hall |
Wednesday
October 24, 2007
|
12:15 PM |
1:15 PM |
Craig Lindsley and Dave Weaver, Vanderbilt University, Department of Pharmacology, “Discovery, Refinement, and Characterization of Novel M1 antagonists: A Technology-enabled Approach” |
1220 MRBIII |
Tuesday
October 30, 2007 |
4:15 PM |
5:15 PM |
Anne Andrews, Penn State University: "Influence of Serotonin Transporter Gene Variants on Uptake and Anxiety." Jointly sponsored by the Department of Chemistry and the Vanderbilt Institute of Chemical Biology. |
4327 Stevenson Center |
Wednesday
November 7, 2007
|
12:15 PM |
1:15 PM |
George Hartman, Executive Director, Department of Medicinal Chemistry, Merck Research Labs, "Kinesin Spindle Protein Inhibitors-Optimization of Leads to Drug Candidates" |
1220 MRBIII
|
Wednesday
November 14, 2007
|
12:15 PM |
1:15 PM |
Christine Hrycyna, Department of Chemistry, Purdue University, (Lecture 1) “Ras Protein Isoprenylcysteine Carboxylmethyltransferases: Molecular Characterization and the Development of Inhibitors” |
1220 MRBIII |
Wednesday
November 14, 2007 |
4:00 PM |
5:00 PM |
Christine Hrycyna, Department of Chemistry, Purdue University, (Lecture 2) "Careers for the 21st Century Research and Teaching at a Research University." Jointly sponsored by the Center for Structural Biology. |
512 Light Hall |
Wednesday
November 28, 2007
|
12:15 PM |
1:15 PM |
Kip Guy, St. Jude Children’s Research Hospital, "Therapeutic Approaches for Human African Trypanosomiasis" |
1220 MRBIII |
Wednesday
December 12, 2007
|
12:15 PM |
1:15 PM |
Eric Skaar, Vanderbilt University, Department of Microbiology and Immunology, "The Battle for Metal Between Staphylococcus Aureus and Its Host" |
1220 MRBIII |
| |
|
|
|
|
| |
|
|
Spring 2008 Schedule |
|
| |
|
|
|
|
| Date |
Starts |
Ends |
Presenter / Title |
Location |
Wednesday
January 30, 2008 |
12:15 PM |
1:15 PM |
Russell Petter, Vice President of Research, Mersana Therapeutics, Inc., “Discovery and Development of Novel Adenosine A1 Receptor Antagonist” |
1220 MRBIII |
Wednesday
February 6, 2008 |
12:15 PM |
1:15 PM |
Jens Meiler, Vanderbilt University, Department of Chemistry, “Machine Learning for Virtual High-Throughput Screening” |
1220 MRBIII |
Wednesday
February 13, 2008 |
12:15 PM |
1:15 PM |
Shaun Stauffer, Merck, Inc., "Novel Inhibitors of b-Site APP Cleaving Enzyme (BACE-1)" |
1220 MRBIII |
Wednesday
February 20, 2008 |
12:15 PM |
1:15 PM |
Shahriar Mobashery, University of Notre Dame, “Chemistry of Resistance to b-Lactam Antibiotics in Methicillin-Resistant Staphylococcus aureus (MRSA)” |
1220 MRBIII |
Wednesday
February 27, 2008 |
12:15 PM |
1:15 PM |
Annette Beck-Sickinger, Institute of Biochemistry, University of Leipzig, Germany, “Neuropeptide Y Receptors: Diversity and Similarities in Subtype Selective Ligand Binding,” Co-hosted by the Department of Chemistry |
1220 MRBIII |
Wednesday
March 5, 2008 |
12:15 PM |
1:15 PM |
Borden Lacy, Vanderbilt University, Department of Microbiology and Immunology, "Structural Analysis of Helicobacter Pylori Vacuolating Toxin (VacA)" |
1220 MRBIII |
Wednesday
March 12, 2008 |
12:15 PM |
1:15 PM |
Tina Iverson, Vanderbilt University, Department of Pharmacology, "Shedding light of photosynthesis with the structure of photosystem II" |
1220 MRBIII |
Wednesday
April 2, 2008
|
12:15 PM |
1:15 PM |
Wellington Pham, Vanderbilt University, Department of Radiology and Radiological Sciences, "Tracking Dendritic Cells: Implications of Imaging in Cellular Therapy" |
1220 MRBIII |
Friday
April 4, 2008 |
4:00 PM |
5:00 PM |
Henry Forman, University of California, Merced. "Signaling in Response to Elecrophiles; What Doesn't Kill You Makes You Stronger." Co-sponsored by the Institute for Global Health, the Center in Molecular Toxicology, and the Vanderbilt Institute of Chemical Biology |
512 Light Hall |
Wednesday
April 9, 2008 |
12:15 PM |
1:15 PM |
Brandt Eichman, Vanderbilt University, Department of Biological Sciences, "New Protein Architectures for Processing DNA" |
1220 MRBIII |
Wednesday
April 16, 2008
|
12:15 PM |
1:15 PM |
Matthew Shair, Harvard University, Department of Chemistry and Chemical Biology, "Synthesis Studies of the Lomaiviticins Leading to Discovery of New Reactions" |
1220 MRBIII |
Wednesday
April 30, 2008 |
12:15 PM |
1:15 PM |
Richard Baltz, Cubist Pharmaceuticals, "Production of Novel Acidic Lipopeptide Antibiotics by Genetic Engineering in Streptomyces Roseosorus" |
1220 MRBIII |
Wednesday
May 7, 2008 |
12:15 PM |
1:15 PM |
Scott Wolkenberg, Merck & Co. , "Application of an Iterative Analogue Library Approach to the Discovery of Potent and Selective Somatostatin Recepter Subtype 2 (SSTR2) Agonists" |
1220 MRBIIII |
